首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1642839

2025-2033 年口服蛋白質和胜肽市場規模、佔有率、趨勢和預測（按藥物類型、應用和地區分類）

Oral Proteins and Peptides Market Size, Share, Trends, and Forecast by Drug Type, Applications, and Region, 2025-2033

出版日期: 2025年01月18日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2024年，全球口服蛋白和胜肽市場規模為18IMARC Group美元。北美目前在市場上佔據主導地位，到2024年，其市場佔有率將超過97.8%。主要促進因素包括糖尿病和癌症等慢性病的盛行率不斷上升，以及生物技術公司和研究機構之間持續合作促進創新。

蛋白質和胜肽是人體的天然成分，在許多生物過程中發揮重要作用。由於其結構複雜且易於在胃和小腸中消化，因此通常透過注射給藥。然而，口服蛋白質和胜肽可以透過口服途徑攝取來治療荷爾蒙、胃和代謝紊亂。它們旨在透過使用專門的配方來克服這些挑戰，這些配方可以保護分子免於消化，並允許它們透過腸壁吸收到血液中。這些製劑包括腸溶衣、奈米顆粒和其他遞送技術。口服蛋白質和胜肽廣泛用於治療多種慢性疾病，例如糖尿病、癌症和自體免疫疾病。

口服蛋白質和胜肽市場趨勢：

患有癌症、糖尿病、心血管疾病（CVD）和後天免疫缺乏症候群（AID）等慢性疾病的患者數量不斷增加，以及老年人口的不斷擴大，是推動口服蛋白質和胜肽市場成長的關鍵因素。除此之外，大眾偏好的轉變以及對有效口服藥物和技術的需求不斷成長也促進了市場的成長。此外，消費者健康意識的不斷增強以及對口服蛋白質和胜肽補充劑的眾多益處的認知不斷增強，正在為市場創造積極的前景。除此之外，3D（3D）列印、奈米技術和基因工程等創新技術進步使製造商能夠生產更先進、更具成本效益的產品變體，這是另一個重要的成長誘導因素。同時，製藥公司之間的廣泛合作、醫療保健基礎設施的重大進步以及不斷增加的研發 (R&D) 活動為市場帶來了豐厚的成長機會。此外，消費者可支配收入的增加，富含蛋白質的飲食的廣泛採用，對蛋白粉、蛋白棒和奶昔的需求激增，以及提供便捷產品獲取的在線平台的日益增多，都有助於市場擴張。

The global oral proteins and peptides market size was valued at USD 1.8 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 3.4 Billion by 2033, exhibiting a CAGR of 7.13% from 2025-2033. North America currently dominates the market, holding a market share of over 97.8% in 2024. The market is growing due to advancements in drug delivery technologies and the rising demand for non-invasive treatments. Key drivers include the increasing prevalence of chronic diseases like diabetes and cancer coupled with ongoing collaborations between biotech firms and research institutions fostering innovation.

Proteins and peptides are natural components of the human body and play essential roles in many biological processes. Due to their complex structure and susceptibility to digestion in the stomach and small intestine, they are usually administered through injections. However, oral proteins and peptides can be taken via the oral path to treat hormonal, gastric, and metabolic disorders. They are designed to overcome these challenges by using specialized formulations that protect the molecules from digestion and allow them to be absorbed through the intestinal wall into the bloodstream. These formulations include enteric coatings, nanoparticles, and other delivery technologies. Oral proteins and peptides are extensively utilized to treat numerous chronic diseases, such as diabetes, cancer, and autoimmune disorders.

Oral Proteins and Peptides Market Trends:

The increasing volume of patients suffering from chronic diseases, such as cancer, diabetes, cardiovascular disorders (CVDs), and acquired immunodeficiency syndrome (AIDs), and the expanding geriatric population represent the key factors driving the oral proteins and peptides market growth. Besides this, shifting preferences and the rising demand for effective oral drugs and technology among the masses are contributing to the market growth. Moreover, the escalating consumer health consciousness and the growing awareness of the numerous benefits associated with the consumption of oral protein and peptide supplements are creating a positive outlook for the market. In addition to this, innovative technological advancements, such as three-dimensional (3D) printing, nanotechnology, and genetic engineering, have enabled manufacturers to produce more advanced and cost-effective product variants, which is acting as another significant growth-inducing factor. Concurrent with this, the extensive collaborative efforts between pharmaceutical companies, significant advancements in the healthcare infrastructure, and rising research and development (R&D) activities are presenting remunerative growth opportunities for the market. Furthermore, the inflating disposable income of consumers, the widespread adoption of protein-rich diets, the surging demand for protein powder, bars, and shakes, and the increasing proliferation of online platforms providing easy product access are aiding in market expansion.

Oral Proteins and Peptides Industry Segmentation:

Drug Type Insights:

Linaclotide
Plecanatide
Calcitonin
Insulin
Octreotide

Application Insights:

Gastric and Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders

Regional Insights:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for oral proteins and peptides. Some of the factors driving the North America oral proteins and peptides market included the increasing prevalence of chronic diseases, the shifting consumer preference for oral drugs, and innovative product advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global oral proteins and peptides market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amryt Pharma Plc, AstraZeneca PLC, Biocon Limited, Novo Nordisk A/S, Oramed Ltd, Proxima Concepts Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1.How big is the oral proteins and peptides market?
2.What is the future outlook of oral proteins and peptides market?
3.What are the key factors driving the oral proteins and peptides market?
4.Which region accounts for the largest oral proteins and peptides market share?
5.Which are the leading companies in the global oral proteins and peptides market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Oral Proteins and Peptides Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Type

6.1 Linaclotide
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Plecanatide
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Calcitonin
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Insulin
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Octreotide
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Application

7.1 Gastric and Digestive Disorders
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Bone Diseases
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Diabetes
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Hormonal Disorders
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

9.1 Overview
9.2 Drivers
9.3 Restraints
9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Amryt Pharma Plc
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
- 13.3.2 AstraZeneca PLC
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
  - 13.3.2.3 Financials
  - 13.3.2.4 SWOT Analysis
- 13.3.3 Biocon Limited
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
  - 13.3.3.3 Financials
  - 13.3.3.4 SWOT Analysis
- 13.3.4 Novo Nordisk A/S
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 Oramed Ltd
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 Financials
- 13.3.6 Proxima Concepts Limited
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

簡介目錄圖表

List of Figures

Figure 1: Global: Oral Proteins and Peptides Market: Major Drivers and Challenges
Figure 2: Global: Oral Proteins and Peptides Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Oral Proteins and Peptides Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Oral Proteins and Peptides Market: Breakup by Drug Type (in %), 2024
Figure 5: Global: Oral Proteins and Peptides Market: Breakup by Application (in %), 2024
Figure 6: Global: Oral Proteins and Peptides Market: Breakup by Region (in %), 2024
Figure 7: Global: Oral Proteins and Peptides (Linaclotide) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Oral Proteins and Peptides (Linaclotide) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Oral Proteins and Peptides (Plecanatide) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Oral Proteins and Peptides (Plecanatide) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Oral Proteins and Peptides (Calcitonin) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Oral Proteins and Peptides (Calcitonin) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Oral Proteins and Peptides (Insulin) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Oral Proteins and Peptides (Insulin) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Oral Proteins and Peptides (Octreotide) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Oral Proteins and Peptides (Octreotide) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Oral Proteins and Peptides (Bone Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Oral Proteins and Peptides (Bone Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Oral Proteins and Peptides (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Oral Proteins and Peptides (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Oral Proteins and Peptides (Hormonal Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Oral Proteins and Peptides (Hormonal Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: North America: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: North America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: United States: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: United States: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Canada: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Canada: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Asia-Pacific: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Asia-Pacific: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: China: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: China: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Japan: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Japan: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: India: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: India: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: South Korea: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: South Korea: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Australia: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Australia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Indonesia: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Indonesia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Others: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Europe: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Europe: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Germany: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Germany: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: France: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: France: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: United Kingdom: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: United Kingdom: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Italy: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Italy: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Spain: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Spain: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Russia: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Russia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Others: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Latin America: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Latin America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Brazil: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Brazil: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Mexico: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Mexico: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Others: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Middle East and Africa: Oral Proteins and Peptides Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Middle East and Africa: Oral Proteins and Peptides Market: Breakup by Country (in %), 2024
Figure 73: Middle East and Africa: Oral Proteins and Peptides Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Global: Oral Proteins and Peptides Industry: Drivers, Restraints, and Opportunities
Figure 75: Global: Oral Proteins and Peptides Industry: Value Chain Analysis
Figure 76: Global: Oral Proteins and Peptides Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Oral Proteins and Peptides Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Oral Proteins and Peptides Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
Table 3: Global: Oral Proteins and Peptides Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Oral Proteins and Peptides Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Oral Proteins and Peptides Market: Competitive Structure
Table 6: Global: Oral Proteins and Peptides Market: Key Players

02-2729-4219

+886-2-2729-4219